Search for: "Gilead Sciences Limited"
Results 41 - 60
of 84
Sort by Relevance
|
Sort by Date
30 Aug 2018, 6:18 am
Gilead Sciences, Inc., (discussion by C&M attorneys here), the panel held that Escobar’s two conditions must be satisfied to give rise to an implied-certification claim. [read post]
31 Jul 2018, 7:58 am
The ruling of the CJEU brings to mind the test proposed by Warren J. in Eli Lilly v Human Genom Sciences [2014] EWHC 2404 (Pat) (18 July 2014)). [read post]
27 Feb 2018, 12:24 pm
Once again Fish and Singer— this time with help from Irell & Manella and Orrick—have wriggled out of a massive verdict that a jury slapped on client Gilead Sciences Inc.Fish and Gilead took a $2.5 billion hit in Delaware federal court in December 2016. [read post]
18 Feb 2018, 8:52 am
Delaware overturned a $2.54 billion jury verdict against Gilead and instead ruled that Merck’s patent, asserted against hepatitis C drugs Sovaldi and Harvoni, was invalid.Of past events, see Merck wins $2.54 billion in hepatitis C drug trial against Gilead from 16 Dec 2016:Merck on Thursday was awarded $2.54 billion in royalties by a federal jury in a patent lawsuit against Gilead Sciences over Gilead's blockbuster hepatitis C drugs Sovaldi… [read post]
9 May 2017, 4:42 am
Arnold J. reiterated his view (expressed previously in Teva UK Ltd v Gilead Sciences Inc [2017] EWHC 13 (Pat)) that the test in Lilly remains unclear. [read post]
9 Aug 2016, 10:50 am
As an American lawyer traveling in the Middle East, at the border between Israel and the West Bank, I can’t help but focus on the big, red sign that says, “This Road leads to Area ‘A’ Under The Palestinian Authority. [read post]
31 Jul 2016, 9:30 pm
Gilead Sciences spent $11 billion to acquire the rights to Sovaldi in 2011, and put it on the market in 2013. [read post]
8 Apr 2016, 6:55 pm
Harvoni, developed by Gilead Sciences, Inc., is now viewed by doctors as a medically necessary treatment for Hepatitis C. [read post]
19 Jan 2016, 3:56 pm
Gilead Sciences, Inc. v. [read post]
8 Jan 2016, 5:26 am
’ In re Gilead Sciences Securities Litigation, 536 F.3d 1049 (U.S. [read post]
4 Oct 2015, 11:35 am
Hiltzik recalled how earlier this year, another member of the Big Pharma club, Gilead Sciences, limited its patient-assistance program for Sovaldi and Harvoni, drugs that treat hepatitis C for more money than most people make in a year. [read post]
26 Jun 2015, 12:30 am
Actually, Mr Justice Arnold had himself moved away from the idea already - he distinguished his decision in the later case of Idenix Pharmaceutical, Inc v Gilead Sciences, Inc (reported by IPKat here) in which he declined to construe a claim narrowly on the basis of the prosecution history.This did not however have any effect on the outcome - Floyd LJ otherwise endorsed Arnold J's application of the Protocol questions to likewise find that there was no direct… [read post]
5 Mar 2015, 6:00 am
Gilead Sciences, Inc. v. [read post]
5 Jan 2015, 5:08 am
This, in chronological order and excluding regular omnibus posts, is what we brought you last week:* The SKYVolt's the limit, even if you forget the wind, sun and water ...Jeremy writes about Stone Electrical Ltd v British Sky Broadcasting Group plc, a decision of the Irish Patents Office that considered whether a ‘SKYVolt Generators of power by Wind, Sun and Water’ sign for goods and services related to renewable energy could be registered in the face of BSkyB’s… [read post]
23 Dec 2014, 6:10 pm
Many have been limiting treatment to only the sickest patients. [read post]
7 Dec 2014, 3:29 pm
‘It’s Idenix Pharmaceutical, Inc v Gilead Sciences, Inc & Others [2014] EWHC 3916 (Pat) (01 December 2014)’, Darren might answer. [read post]
2 Dec 2014, 7:35 am
The judgment is available here on BAILII, and the case is properly called Idenix Pharmaceutical, Inc v Gilead Sciences, Inc & Ors [2014] EWHC 3916 (Pat) (01 December 2014).The technical field is treatments for Hepatitis C; the specific area is nucleoside analogues having alleged activity against Hepatitis C Virus and other viruses of the Flaviviridae family. [read post]
10 Aug 2014, 6:54 pm
Writing in the New York Times, Margot Sanger-Katz acknowledges that although the drug is a legitimate breakthrough in the treatment for the liver disease caused by hep C, many people accuse its manufacturer, Gilead Sciences, of setting an unreasonable and unsustainable price for it, at $1,000 per pill. [read post]
27 Apr 2014, 10:00 pm
In Gilead Sciences, Inc. v. [read post]
23 Apr 2014, 6:47 pm
Gilead Sciences, Inc., Rader, CJ Op. at *1. [read post]
